AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice

  title={AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice},
  author={Ching-Shuen Wang and Christina L. M. Maruyama and Justin T. Easley and Bryan G. Trump and Olga J Baker},
  booktitle={Scientific reports},
Sjögren's syndrome (SS) is a chronic inflammatory autoimmune disease characterized by diminished secretory function of the exocrine glands. Treatments for hyposalivation are limited to the use of saliva substitutes and medications that provide only temporary relief. In light of the high degree of need and the limitations of current therapies, development of alternative treatments to restore functioning is essential. Resolvins (Rv), which are highly potent lipid mediators, offer a viable… CONTINUE READING


Publications citing this paper.

Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats

Molecular Brain • 2018
View 3 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 55 references

Signaling Pathways of Purinergic Receptors and Their Interactions with Cholinergic and Adrenergic Pathways in the Lacrimal Gland.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics • 2016

The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis

H Benabdoune
Inflamm Res, doi: 10.1007/s00011-016-0946-x • 2016

Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β -C/EBPβ pathway

T Maekawa
Nature Communications • 2015

Modulation of the inflammatory response to chitosan through M2 macrophage polarization using proresolution mediators

Vasconcelos, P D.
Biomaterials • 2015

Similar Papers

Loading similar papers…